Clinical Observation: Clinical Trials

49 trials of Clinical Observation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

19 completed, 11 unknown, 10 active not recruiting, 5 terminated. 22 Phase 3, 12 Phase 2, 4 Not applicable, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 322Completed 12, Active not recruiting 7, Unknown 2, Terminated 1
Phase 212Active not recruiting 3, Completed 3, Terminated 3, Suspended 2, Unknown 1
Not applicable4Active not recruiting 1, Completed 1, Unknown 1, Withdrawn 1
Phase 12Active not recruiting 1, Terminated 1

Follow Clinical Observation: new trials by email Literature Review of Clinical Observation trials Research Report on Clinical Observation

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
Biospecimen Collection, Bone Scan, Clinical Observation - Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 2SuspendedMayo Clinic2362024-05-032026-08-20
Observational Study for Perioperative Care of Patients Requiring ICU (OPICU)
Clinical Observation - Indication, Unlabeled, Complication,Postoperative
UnknownKoç University13002024-01-032024-01-31
Clinical and Electronic Record for Patients With COVID-19 Treated With the Assisted Breathing Helmet - ELMO in Ceará
Clinical Observation - COVID-19
UnknownEscola de Saúde Pública do Ceará20002021-09-012022-06-14
White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA
Clinical Observation, Patient Observation, Questionnaire Administration - Prostate Adenocarcinoma, PSA Failure
Phase 2SuspendedCity of Hope Medical Center1332021-05-102026-11-04
A Clinical Trial for Hospitalized Patients With COVID-19 in Ceará: ResCOVID Study
Clinical Observation - COVID-19
UnknownEscola de Saúde Pública do Ceará30002020-04-022020-12-02
Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer
Biospecimen Collection, Clinical Observation, Computed Tomography - Localized Renal Pelvis and Ureter Urothelial Carcinoma, Locally Advanced Bladder Urothelial Carcinoma
Phase 3Active not recruitingNational Cancer Institute (NCI)7392017-11-032026-10-26
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
Biospecimen Collection, Clinical Observation, Intensity-Modulated Radiation Therapy - Grade 2 Meningioma, Intracranial Meningioma
Phase 3Active not recruitingNRG Oncology1622017-09-122026-10-02
Chorioamnionitis: Observation of at Risk Infants vs Standard Care
Clinical observation, Standard management - Chorioamnionitis, Early Onset Neonatal Sepsis
Not applicableWithdrawnIRCCS Burlo Garofolo2016-10-012019-07-12
Multicenter Study of Impulse Oscillometry in Chinese
Clinical Observation - Healthy Subjects, Chronic Obstructive Pulmonary Disease
UnknownGuangzhou Institute of Respiratory Disease40002016-09-012018-03-16
Perceptions of Side Effects of Cancer Chemoradiotherapy
Clinical Observation - Malignant Neoplasm, Side Effect
CompletedUniversity of Southern California622016-06-012018-10-05
Testing Nivolumab to Prevent Disease From Coming Back After Treatment in Patients With Acute Myeloid Leukemia, REMAIN Trial
Biospecimen Collection, Bone Marrow Biopsy, Clinical Observation - Acute Myeloid Leukemia
Phase 2Active not recruitingNational Cancer Institute (NCI)822015-07-022026-11-03
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Clinical Observation, Crizotinib, Laboratory Biomarker Analysis - ALK Gene Rearrangement, ALK Gene Translocation
Phase 3Active not recruitingECOG-ACRIN Cancer Research Group1662015-03-232025-12-19
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Clinical Observation, Erlotinib Hydrochloride, Laboratory Biomarker Analysis - Lung Non-Squamous Non-Small Cell Carcinoma, Stage IB Lung Non-Small Cell Carcinoma AJCC v7
Phase 3Active not recruitingNational Cancer Institute (NCI)3902015-02-112026-07-02
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Biospecimen Collection, Carboplatin, Cisplatin - Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7
Not applicableActive not recruitingNational Cancer Institute (NCI)74582014-09-262026-10-26
Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions
imiquimod, fluorouracil, infrared photocoagulation therapy - Anal Cancer, High-grade Squamous Intraepithelial Lesion
Phase 3CompletedAIDS Malignancy Consortium44462014-09-242024-07-26
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
Biopsy Procedure, Bone Marrow Aspiration, Bone Marrow Biopsy - Ganglioneuroblastoma, Localized Resectable Neuroblastoma
Phase 3Active not recruitingChildren's Oncology Group3912014-08-082026-10-13
Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
Bone Scan, Cisplatin, Clinical Observation - EBV Infection, Stage II Nasopharyngeal Carcinoma AJCC v7
Phase 2 / Phase 3Active not recruitingNRG Oncology9242014-07-012026-10-13
Comparability of Bispectral Index and NeuroSENSE in Aged Patients
EEG monitoring with Bispectral Index and NeuroSENSE, Clinical observation - Sleep
WithdrawnHopital Foch2013-11-012016-10-31
Radiation Therapy and Rituximab in Treating Patients With Stage I-II Grade 1 or Grade 2 Follicular Lymphoma
Clinical Observation, Radiation Therapy, Rituximab - Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2 Follicular Lymphoma
Phase 1 / Phase 2Active not recruitingM.D. Anderson Cancer Center812013-05-202026-08-12
Biomarkers in Post-Menopausal Women Receiving Flaxseed
Clinical Observation, Flaxseed, Laboratory Biomarker Analysis - No Evidence of Disease
Not applicableCompletedRoswell Park Cancer Institute2582012-12-142022-05-09

Showing 20 of 49. Sign in to see all of them.

Conditions studied

Carcinoma, Non-Small-Cell Lung (8)  ·  Prostatic Neoplasms (6)  ·  Leukemia, Myeloid, Acute (4)  ·  Breast Neoplasms (3)  ·  Lung Neoplasms (3)  ·  Neuroblastoma (3)  ·  Anus Neoplasms (2)  ·  Bile Duct Neoplasms (2)  ·  Breast Neoplasms, Male (2)  ·  COVID-19 (2)  ·  Colonic Neoplasms (2)  ·  Congenital Abnormalities (2)  ·  Gallbladder Neoplasms (2)  ·  HIV Infections (2)  ·  Leukemia, Erythroblastic, Acute (2)

Sponsors

National Cancer Institute (NCI) (9)  ·  Children's Oncology Group (4)  ·  AIDS Malignancy Consortium (2)  ·  Alliance for Clinical Trials in Oncology (2)  ·  Children's Cancer and Leukaemia Group (2)  ·  ECOG-ACRIN Cancer Research Group (2)  ·  Escola de Saúde Pública do Ceará (2)  ·  European Organisation for Research and Treatment of Cancer - EORTC (2)  ·  Gynecologic Oncology Group (2)  ·  M.D. Anderson Cancer Center (2)  ·  Mayo Clinic (2)  ·  NRG Oncology (2)  ·  Roswell Park Cancer Institute (2)  ·  Cancer and Leukemia Group B (1)  ·  City of Hope Medical Center (1)

Countries

United States (32)  ·  Canada (12)  ·  Puerto Rico (8)  ·  Australia (7)  ·  France (6)  ·  United Kingdom (4)  ·  Guam (3)  ·  Italy (3)  ·  New Zealand (3)  ·  Belgium (2)  ·  Brazil (2)  ·  China (2)  ·  Germany (2)  ·  Ireland (2)  ·  Japan (2)

Top investigators

Marcelo A Holanda, PHD (2)  ·  Alberto S. Pappo, MD (1)  ·  Amy A Smith (1)  ·  Andrea B Apolo (1)  ·  Anna C Ferrari (1)  ·  Arkadiusz Dudek, MD (1)  ·  Atif Akdas, MD (1)  ·  Bouthaina S Dabaja (1)  ·  Brian Slomovitz (1)  ·  Bruno De Bernardi, MD (1)  ·  Bryan J. Donnelly, MD, FRCSC, MSC (1)  ·  Cecile Le Pechoux, MD (1)  ·  Chad Tang (1)  ·  Clayton S Lau (1)  ·  Clive Stubbs (1)

Results publications

PMID 16921051, PMID 20522709, PMID 20823433, PMID 21940214, PMID 22782416, PMID 22998715, PMID 23550669, PMID 25087673, PMID 26720308, PMID 27789196, PMID 28391003, PMID 29068800, PMID 29376112, PMID 30054691, PMID 30060087, PMID 30954717, PMID 31044307, PMID 31375516, PMID 31483448, PMID 31652094, PMID 31678224, PMID 31786124, PMID 33394722, PMID 33548339, PMID 33594934, PMID 34277060, PMID 34623899, PMID 34919827, PMID 35261959, PMID 35297944, PMID 35416975, PMID 35704479, PMID 35759733, PMID 36184192, PMID 36566574, PMID 36610886, PMID 36947198, PMID 38661512, PMID 38757485, PMID 39282902, PMID 39390760, PMID 39928953, PMID 39938471, PMID 41386267, PMID 41609418, PMID 42641639

NIH funding

U10CA180868 (5), U10CA021115 (4), U10CA031946 (4), U10CA098543 (4), U10CA180820 (4), U10CA180821 (4), U10CA027469 (3), U10CA180830 (3), U10CA180886 (3), P30CA014599 (2), U01CA121947 (2), U24CA196172 (2), N01CM00071 (1), P30CA014089 (1), P30CA016056 (1)